IEEE Trans Ultrason Ferroelectr Freq Control. 2021 Jun;68(6):2059-2074. doi: 10.1109/TUFFC.2021.3055141. Epub 2021 May 25.
There has been growing interest in nanobubbles (NBs) for vascular and extravascular ultrasound contrast imaging and therapeutic applications. Studies to date have generally utilized low frequencies (<12 MHz), high concentrations (>10 mL), and uncalibrated B-mode or contrast-mode on commercial systems without reporting investigations on NB signatures upon which the imaging protocols should be based. We recently demonstrated that low concentrations (10 mL) of porphyrin-lipid-encapsulated NBs scatter nonlinearly at low (2.5, 8 MHz) and high (12.5, 25, 30 MHz) frequencies in a pressure threshold-dependent manner that is advantageous for amplitude modulation (AM) imaging. Here, we implement pressure-calibrated AM at high frequency on a commercial preclinical array system to enhance sensitivity to nonlinear scattering of three phospholipid-based NB formulations. With this approach, improvements in contrast to tissue ratio relative to B-mode between 12.4 and 22.8 dB are demonstrated in a tissue-mimicking phantom, and between 6.7 and 14.8 dB in vivo.
人们对纳米气泡 (NBs) 在血管和血管外超声对比成像和治疗应用中的应用越来越感兴趣。迄今为止的研究通常利用低频率 (<12 MHz)、高浓度 (>10 mL) 和未经校准的 B 模式或对比模式在商业系统上进行,而没有报告基于成像协议的 NB 特征的研究。我们最近证明,低浓度 (10 mL) 的卟啉脂质包封的 NBs 以压力阈值依赖的方式在低 (2.5、8 MHz) 和高 (12.5、25、30 MHz) 频率下非线性散射,这有利于幅度调制 (AM) 成像。在这里,我们在商业临床前阵列系统上实施高频压力校准的 AM,以提高对三种基于磷脂的 NB 制剂非线性散射的灵敏度。通过这种方法,在组织模拟体模中,与 B 模式相比,对比度相对于组织的比值提高了 12.4 至 22.8 dB,在体内提高了 6.7 至 14.8 dB。